Les perspectives thérapeutiques pharmacologiques du vasospasme cérébral
- 31 December 1996
- journal article
- Published by Elsevier in Annales Françaises dʼAnesthésie et de Réanimation
- Vol. 15 (3) , 374-381
- https://doi.org/10.1016/s0750-7658(96)80022-0
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The role of hemolysate in the facilitation of oxyhemoglobin-induced contraction in rabbit basilar arteriesJournal of Neurosurgery, 1994
- Cytotoxic effects of bloody cerebrospinal fluid on cerebral endothelial cells in cultureJournal of Neurosurgery, 1994
- Hemoglobin penetration in the wall of the rabbit basilar artery after subarachnoid hemorrhage and intracisternal hemoglobin injectionActa Neurochirurgica, 1993
- Single Intracisternal Bolus of Recombinant Tissue Plasminogen Activator in Patients with Aneurysmal Subarachnoid HemorrhageNeurosurgery, 1992
- Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1991
- Prevention of Vasospasm by Clot Removal and Intrathecal Bolus Injection of Tissue-Type Plasminogen Activator: Preliminary ReportNeurosurgery, 1991
- Evidence of the role of hemolysis in experimental cerebral vasospasmJournal of Neurosurgery, 1990
- Safety and Efficacy of Intrathecal Thrombolytic Therapy in a Primate Model of Cerebral VasospasmNeurosurgery, 1989
- Erythrocytes are essential for development of cerebral vasculopathy resulting from subarachnoid hemorrhage in cats.Stroke, 1988
- Relation of Cerebral Vasospasm to Subarachnoid Hemorrhage Visualized by Computerized Tomographic ScanningNeurosurgery, 1980